Best New Hope for Mesothelioma Diagnosis and Treatment in 2016
Living with malignant mesothelioma can be an emotional roller coaster. On one hand, the prognosis for mesothelioma patients remains relatively poor, in spite of intense research going on around the globe. On the other hand, new studies released within the past year indicate that 2016 could be the most hopeful year yet for mesothelioma sufferers and their families. Potential New Mesothelioma Drug While Alimta (pemetrexed) remains the only medication that is FDA-approved specifically for pleural mesothelioma treatment, other new drugs are showing encouraging results. One of those is the monoclonal antibody Keytruda (pembrolizumab) which is designed to block a cell surface protein called PD-1. This protein is believed to be expressed by up to 40 percent of mesothelioma tumors. In…